TB-500
5mg
Thymosin Beta-4 fragment referenced in published literature investigating actin-binding mechanisms and angiogenesis biology.
$50.00
Explore → Shop
VIEW ALL RECOVERY
RECOVERY
BPC-157
10mg
$70.00
RECOVERY
BPC-15710mg
$70.00
1
2 available · Ships within 48 hours
- Third-Party TestedThird-Party Tested
- Cold-Chain HandledCold-Chain Handled
- Concierge SupportConcierge Support
Questions about this compound, specifications, or documentation?
Speak with the ConciergeBody Protection Compound (BPC-157). Pentadecapeptide referenced across published literature investigating angiogenic signaling, nitric-oxide pathway biology, and gastrointestinal epithelial mechanisms. Lyophilized, sterile-filled, 99.5%+ purity.
- Mitochondrial biology research
- Cellular bioenergetics
- Cold-chain handled, third-party tested
VIEW BATCH COA
Independent lab verification · current batch
- THIRD-PARTY TESTED
- COLD-CHAIN HANDLED
- TRACKED SHIPPING
- QUALITY-FOCUSED SOURCING
SPECIFICATIONS
- Product
- BPC-157
- Strength
- 10mg
- Vial Size
- 10mg per vial
- SKU
- VLR-BPC-10
- Batch / Lot
- Current batch listed on COA
- Storage
- Refrigerate 2–8°C · protect from light
- Form
- Lyophilized powder
RESEARCH USE ONLY
Sold strictly for laboratory and research purposes — never for human consumption, food, drug, or cosmetic use. 21+ only. A standard we hold ourselves to, not just the law.
EDUCATIONAL OVERVIEW
About this compound
Context, not noise — what the research actually says.
WHAT IT IS
A research compound investigated in mitochondrial biology and cellular bioenergetics literature.
RECOVERY
KEY BENEFITS
- Studied in cellular bioenergetic pathways
- Investigated in oxidative-balance literature
- Referenced in sirtuin and cellular-signaling research
COMMON USES
- Mitochondrial biology research
- Cellular bioenergetics studies
- Foundational layer across the catalog
THINGS TO KNOW
- Lyophilized — requires reconstitution with BAC water
- Refrigerate; protect from light
- Research use only — not for human consumption
RELATED COLLECTION
Glow Research Collection
Pairs with GHK-Cu + TB-500 — A three-vial collection assembled around connective tissue biology and extracellular matrix research.
VIEW COLLECTION
COLLECTION PRICE
$119.00
STORAGE
Cold-chain handling
REFRIGERATED
Store unopened at 36–46°F (2–8°C).
RECONSTITUTED
Keep refrigerated. Do not freeze.
PROTECT FROM LIGHT
Original packaging until use.
Store unopened vials refrigerated at 36–46°F (2–8°C). After reconstitution, keep refrigerated and use within the timeframe specified by your laboratory practice. Protect from light. Do not freeze reconstituted solution.
SHIPPING
Shipping information
Insulated, tracked, and handled with care from our facility to yours.
PROCESSING
Ships within 48 hours of order confirmation.
COLD-CHAIN
Insulated packaging with ice packs for temperature-sensitive compounds.
TRACKED & INSURED
Tracking provided. Domestic delivery typically 2–5 business days.
Local pickup is available by appointment for customers in the Phoenix, Arizona area. See the full shipping policy for details, accepted payment methods, and scheduling.
FAQ
Common questions
SCIENTIFIC RESEARCH OVERVIEW · SRO
Scientific Research Overview
A structured summary of published scientific literature on this compound — provided for educational reference only.
Regenerative Research
RESEARCH SNAPSHOT
- Research Category
- Investigational synthetic gastric pentadecapeptide
- Biological Targets
- Angiogenic Signaling
- Growth Factor Pathways
- Tissue Repair Mechanisms
- Primary Areas of Research
- Connective-tissue repair and remodeling · Angiogenesis and vascular-signaling pathways · Gastrointestinal mucosal integrity · Growth-factor and nitric-oxide biology · Tendon, ligament, and muscle-tissue research · Cytoprotective and anti-inflammatory mechanisms
- Current Stage of Research
- Primarily Preclinical Research
WHAT IS BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a partial sequence of the human gastric protein BPC. It is investigated in the scientific literature as a regenerative research compound across connective-tissue, gastrointestinal, and angiogenesis models. Current evidence is predominantly derived from in vitro and animal studies, with no approved human drug formulation at this time.
PRIMARY AREAS OF RESEARCH
- Connective-tissue repair and remodeling
- Angiogenesis and vascular-signaling pathways
- Gastrointestinal mucosal integrity
- Growth-factor and nitric-oxide biology
- Tendon, ligament, and muscle-tissue research
- Cytoprotective and anti-inflammatory mechanisms
- Published studies have investigated effects on tendon, ligament, muscle, and gastrointestinal-lining models in rodent and cell-culture systems.
- Research suggests modulation of angiogenic markers, including VEGF and VEGFR2 expression, in preclinical wound-healing and tissue-repair studies.
- Current evidence indicates interaction with growth-factor pathways and nitric-oxide signaling, potentially influencing collagen-matrix organization and vascular remodeling.
- Investigators have observed cytoprotective and anti-inflammatory activity in published animal models of gastrointestinal injury and soft-tissue damage.
BPC-157 is being studied for its potential influence on several regenerative signaling axes. Current evidence indicates upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) and modulation of nitric-oxide pathways, which are associated with angiogenesis and blood-flow regulation. Published work also suggests interactions with growth-factor cascades and collagen-related genes involved in extracellular-matrix remodeling. The precise molecular target remains under investigation, and human pharmacokinetic and safety data are limited.
CURRENT AREAS OF INVESTIGATION
- Tissue Regeneration
- Cellular Repair
- Connective Tissue
- Gastrointestinal Research
- Angiogenesis
- Recovery
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2012;18(30):4894-4907. View source
- Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC-157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-19076. View source
- Staresinic M, Petrovic I, Novinscak T, et al. BPC 157's effect on healing of skin wounds in rats. J Physiol Pharmacol. 2009;60 Suppl 7:191-196. View source
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound 157 and the promotion of tendon and ligament healing by tendon outgrowth, cell survival, and cell migration. Vasc Cell. 2019;11:2. View source
- Duzel A, Vukojevic J, Viljetiut A, et al. BPC 157 and blood vessels. Curr Pharm Des. 2022;28(19):1589-1595. View source
RESEARCH STATUS
This compound continues to be investigated in preclinical and/or clinical research. Scientific understanding continues to evolve as additional studies are published.
RESEARCH DISCLAIMER
For laboratory research use only. This information summarizes published scientific literature for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
RELATED · RECOVERY
More from this pillar
RESEARCH DISCLAIMER
All VELOR compounds are sold strictly for laboratory and research purposes only. They are not intended for human consumption, ingestion, or any food, drug, cosmetic, or therapeutic use. By purchasing, you confirm you are 21+ and a qualified researcher or research institution. Statements have not been evaluated by the FDA.
RECOVERY
BPC-157
$70.00
1